Across TCGA pan-cancer cohorts, RNA5SP517 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNA5SP517 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNA5SP517 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP517 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

STAD, KIRC, and KICH are the cancer types where RNA5SP517 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.385	0.742	<.001	75	view →
KIRC	DFS	Tertile	III,IV	0.127	0.744	.002	72	view →
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
ESCA	DFS	Tertile	III,IV	1.000	0.281	.043	12	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RNA5SP517 tumor-vs-normal RNA expression · all RNA5SP517 data types